iDD biotech receives second milestone payment from Genmab with enrolment of fifth patient in Gen1029 safety trial
SafeHeal completes successful first-in-human clinical study of endoluminal bypass sheath aimed at avoiding ostomies in colorectal surgery patients
GamaMabs Pharma to present new data on GM102 at two upcoming scientific conferences in November
Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes
GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102
Minoryx announces dosing of first US patient in phase 2/3 clinical study of MIN-102 (ADVANCE)
ASM Microbe 2018: Nosopharm to present new first-in-class clinical candidate to tackle Enterobacteriaceae infections
ASCO 2018: CarThera presents promising preliminary efficacy data for treating recurrent glioblastoma
